P&K Skin Research Center Co (XKRX:347740) Debt-to-Equity : 0.01 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is P&K Skin Research Center Co Debt-to-Equity?

P&K Skin Research Center Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩354 Mil. P&K Skin Research Center Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩314 Mil. P&K Skin Research Center Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩74,203 Mil. P&K Skin Research Center Co's debt to equity for the quarter that ended in Dec. 2023 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for P&K Skin Research Center Co's Debt-to-Equity or its related term are showing as below:

XKRX:347740' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.02 Max: 0.04
Current: 0.01

During the past 7 years, the highest Debt-to-Equity Ratio of P&K Skin Research Center Co was 0.04. The lowest was 0.01. And the median was 0.02.

XKRX:347740's Debt-to-Equity is ranked better than
99.49% of 195 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs XKRX:347740: 0.01

P&K Skin Research Center Co Debt-to-Equity Historical Data

The historical data trend for P&K Skin Research Center Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

P&K Skin Research Center Co Debt-to-Equity Chart

P&K Skin Research Center Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.04

0.02

0.01

P&K Skin Research Center Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Competitive Comparison of P&K Skin Research Center Co's Debt-to-Equity

For the Diagnostics & Research subindustry, P&K Skin Research Center Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

P&K Skin Research Center Co's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, P&K Skin Research Center Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where P&K Skin Research Center Co's Debt-to-Equity falls into.

P&K Skin Research Center Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

P&K Skin Research Center Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(354.273	+	313.962)	/	74203.218
	=	0.01

P&K Skin Research Center Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(354.273	+	313.962)	/	74203.218
	=	0.01

P&K Skin Research Center Co (XKRX:347740) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

P&K Skin Research Center Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of P&K Skin Research Center Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

P&K Skin Research Center Co (XKRX:347740) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » P&K Skin Research Center Co Ltd (XKRX:347740) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

National Assembly Road 62 -25 Yeongdeungpo-gu, Education Facility Disaster Relief Society Building, 4th Floor, Seoul, KOR, 07236

Website

http://www.pnkskin.com

P&K Skin Research Center Co Ltd is a skin research center. It provides clinical tests for new cosmetics, raw materials, and cosmeceuticals. The company provides skin irritation tests, Stimulation tests, skin wrinkle evaluation, skin texture evaluation, skin whitening evaluation, sweat proof evaluation, skin density measurement, scalp flakiness evaluation, and hair root evaluation. Also, the company provides health food tests, sensory tests, and In Vitro tests.

P&K Skin Research Center Co (XKRX:347740) Headlines

No Headlines